Hyperbaric oxygen therapy market is expected to grow at a significant rate during the forecast period 2019-2025. Hyperbaric oxygen therapy is a treatment procedure in which the inspired oxygen is given at a considerably increased atmospheric pressure. In most of the cases, the HBOT is provided as an adjunct to pharmacologic or surgical interventions; however, in other cases, it represents the primary treatment modality. The increasing prevalence of acute and chronic diseases such as diabetes and skin infections have increased the adoption rate of artificial therapies in healing after-effects of cosmetic surgeries. According to the Centers for Disease Control and Prevention (CDC) in 2017, there were over 30 million people with diabetes in the US. With the HBOT, the amount of oxygen in the patient’s blood is increased which supports in the growth of vessels, which is crucial for diabetics. This, in turn, increase the growth of hyperbaric oxygen therapy market. The growing popularity of adventure activities has considerably increased the incidence rate of wounds and injuries, owing to which, the physiotherapists recommend HBOT for severe wounds. Moreover, the FDA approvals for the therapy equipment in the treatment of gas embolism and diabetes-related disorders such as diabetic foot ulcers are further anticipated to fuel the growth of the market in the near future.
The global hyperbaric oxygen therapy market is further analyzed on the basis geographical regions, including North America, Europe, Asia-Pacific, and Rest of the World. North America held a dominant position in the global HBOT market in 2018. The region has well-developed healthcare infrastructure with significant government investment in improving the healthcare facilities for the mass. Moreover, a rise in the predominance of chronic diseases and disorders such as diabetes and skin infections further contribute to its growth. Asia-Pacific is estimated to witness the fastest growth in the global HBOT market during the forecast period. This is attributed to the rise in healthcare spending and easy accessibility to advanced healthcare facilities in the region.
Some of the players operating in the global HBOT market include Amron International, Inc., Gaumond Medical Group Inc., HAUX-LIFE-SUPPORT GmbH, IHC Merwede Holding B.V., Oxy-Health, LLC, Perry Baromedical Corp., Sechrist Industries, Inc., and many more. The companies are focused on the development of effective treatment solutions for hyperbaric oxygen therapy market to stay competitive in the global market. Geographical expansion, merger & acquisition, partnerships & collaborations, finding a new market or innovate in their core competency in order to expand individual market share are some of the key strategies adopted by major market players.
Research Methodology:
The market study of the global HBOT market is incorporated by extensive primary and secondary research conducted by a research team at OMR. Secondary research has been conducted to refine the available data to break down the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macroeconomic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings the authenticity of our reports.
Secondary Sources Include
The report is intended for biotechnology providers, research organizations, investment companies, government organizations for overall market analysis and competitive analysis. The report will serve as a source for 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions.
Market Segmentation:
The Report Covers
1. Report Summary
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
1.2.2. By Geography
1.2.3. By Stakeholders
2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
2.3. Rules & Regulations
3. Competitive Landscape
3.1. Competitive Dashboard
3.2. Key Strategy Analysis
3.3. Key Company Analysis
3.3.1. Environmental Tectonics Corp.
3.3.1.1. Overview
3.3.1.2. SWOT Analysis
3.3.1.3. Recent Developments
3.3.2. IHC Merwede Holding B.V.
3.3.2.1. Overview
3.3.2.2. SWOT Analysis
3.3.2.3. Recent Developments
3.3.3. HAUX-LIFE-SUPPORT GmbH
3.3.3.1. Overview
3.3.3.2. SWOT Analysis
3.3.3.3. Recent Developments
3.3.4. Fink Engineering Pty Ltd.
3.3.4.1. Overview
3.3.4.2. SWOT Analysis
3.3.4.3. Recent Developments
4. Market Determinants
4.1. Motivators
4.2. Restraints
4.3. Opportunities
5. Market Segmentation
5.1. Global HBOT Market by Product Type
5.1.1. Monoplace HBOT Devices
5.1.2. Topical HBOT Devices
5.1.3. Multiplace HBOT Devices
5.2. Global HBOT Market by Application
5.2.1. Wound Healing
5.2.2. Decompression Sickness
5.2.3. Infection Treatment
5.2.4. Gas Embolism
5.2.5. Others (Anemia and Gangrene)
6. Regional Analysis
6.1. North America
6.1.1. United States
6.1.2. Canada
6.2. Europe
6.2.1. UK
6.2.2. Germany
6.2.3. Italy
6.2.4. Spain
6.2.5. France
6.2.6. Rest of Europe
6.3. Asia-Pacific
6.3.1. China
6.3.2. Japan
6.3.3. India
6.3.4. Rest of Asia-Pacific
6.4. Rest of the World
7. Company Profiles
7.1. Amron International, Inc.
7.2. Barox HBO
7.3. Comex SA
7.4. Environmental Tectonics Corp.
7.5. Fink Engineering Pty Ltd.
7.6. Gaumond Medical Group Inc.
7.7. Gulf Coast Hyperbarics, Inc
7.8. HAUX-LIFE-SUPPORT GmbH
7.9. Hearmec Co., Ltd.
7.10. Hyperbaric SAC
7.11. IHC Merwede Holding B.V.
7.12. Oxygen Generating Systems Intl.
7.13. Oxy-Health, LLC
7.14. Pan America Hyperbarics, Inc.
7.15. PCCI, INC. (Reimers Systems Inc.)
7.16. Perry Baromedical Corp
7.17. Sechrist Industries, Inc.
7.18. Shared Health Services, Inc.
7.19. SOS Group Global Ltd.
7.20. Tekna Manufacturing Pvt. Ltd.
7.21. Valir Health, LLC